Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2011

Open Access 01-12-2011 | Research article

Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial

Authors: Yuanyuan Wang, Stephen Hall, Fahad Hanna, Anita E Wluka, Gail Grant, Paul Marks, Marie Feletar, Flavia M Cicuttini

Published in: BMC Musculoskeletal Disorders | Issue 1/2011

Login to get access

Abstract

Background

Although viscosupplementation is an effective symptomatic treatment for knee osteoarthritis (OA), the effect of longer term administration on articular cartilage has not been fully explored. We examined the effect of viscosupplementation with Hylan G-F 20 on knee cartilage over 2 years in patients with knee OA.

Methods

In this prospective, single-blind, parallel control group pilot study, 78 patients with symptomatic knee OA (Kellgren-Lawrence grade II and III) were assigned to either intervention group (n = 39 receiving 4 courses of 3 × 2.0 ml of intra-articular Hylan G-F 20 injections at 6 month intervals) or control group (n = 39 receiving usual care for knee OA without injections). Magnetic resonance imaging of the study knee was performed at baseline, 12 and 24 months. Cartilage volume and defects were assessed using validated methods.

Results

Fifty-five subjects (71%) completed 24 month follow up. Over 24 months, the intervention group had a reduced annual percentage rate of medial and lateral tibial cartilage volume loss (mean ± SD, -0.3 ± 2.7% and -1.4 ± 4.3%) compared with the control group (2.3 ± 2.6% and 1.4 ± 2.6%, P = 0.001 and 0.005 for difference, respectively). The intervention group also showed reduced cartilage defect score increment in the medial tibiofemoral compartment (0.1 ± 1.3) compared with the control group (0.8 ± 1.5, P = 0.05).

Conclusions

Six monthly intra-articular injections of Hylan G-F 20 administered to patients with symptomatic knee OA have a beneficial effect on knee cartilage preservation measured by both cartilage volume and cartilage defects. Hylan G-F 20 warrants further evaluation in larger clinical trials as a possible disease-modifying agent in the treatment of knee OA.

Trial Registration

The study was registered with ClinicalTrials.gov (NCT00393393).
Appendix
Available only for authorised users
Literature
1.
Brooks PM: Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr Opin Rheumatol. 2002, 14 (5): 573-577. 10.1097/00002281-200209000-00017.CrossRefPubMed
2.
Felson DT: An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am. 2004, 42 (1): 1-9. 10.1016/S0033-8389(03)00161-1. vCrossRefPubMed
3.
Fam H, Bryant JT, Kontopoulou M: Rheological properties of synovial fluids. Biorheology. 2007, 44 (2): 59-74.PubMed
4.
Pelletier JP, Martel-Pelletier J: The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol Suppl. 1993, 39: 19-24.PubMed
5.
Brzusek D, Petron D: Treating knee osteoarthritis with intra-articular hyaluronans. Curr Med Res Opin. 2008, 24 (12): 3307-3322. 10.1185/03007990802490124.CrossRefPubMed
6.
Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G: Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006, CD005321-2
7.
Takahashi K, Goomer RS, Harwood F, Kubo T, Hirasawa Y, Amiel D: The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage. 1999, 7 (2): 182-190. 10.1053/joca.1998.0207.CrossRefPubMed
8.
Hulmes DJ, Marsden ME, Strachan RK, Harvey RE, McInnes N, Gardner DL: Intra-articular hyaluronate in experimental rabbit osteoarthritis can prevent changes in cartilage proteoglycan content. Osteoarthritis Cartilage. 2004, 12 (3): 232-238. 10.1016/j.joca.2003.11.007.CrossRefPubMed
9.
Marshall KW, Manolopoulos V, Mancer K, Staples J, Damyanovich A: Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis. J Orthop Res. 2000, 18 (3): 416-425. 10.1002/jor.1100180313.CrossRefPubMed
10.
Smith MM, Cake MA, Ghosh P, Schiavinato A, Read RA, Little CB: Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy. Rheumatology (Oxford). 2008, 47 (8): 1172-1178. 10.1093/rheumatology/ken219.CrossRef
11.
Frizziero L, Govoni E, Bacchini P: Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol. 1998, 16 (4): 441-449.PubMed
12.
Pasquali Ronchetti I, Guerra D, Taparelli F, Boraldi F, Bergamini G, Mori G, Zizzi F, Frizziero L: Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology (Oxford). 2001, 40 (2): 158-169. 10.1093/rheumatology/40.2.158.CrossRef
13.
Guidolin DD, Ronchetti IP, Lini E, Guerra D, Frizziero L: Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthritis Cartilage. 2001, 9 (4): 371-381. 10.1053/joca.2000.0398.CrossRefPubMed
14.
Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B, Dougados M: Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage. 1997, 5 (3): 153-160. 10.1016/S1063-4584(97)80010-6.CrossRefPubMed
15.
Jubb RW, Piva S, Beinat L, Dacre J, Gishen P: A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract. 2003, 57 (6): 467-474.PubMed
16.
Cubukcu D, Ardic F, Karabulut N, Topuz O: Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol. 2005, 24 (4): 336-341. 10.1007/s10067-004-1043-z.CrossRefPubMed
17.
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986, 29 (8): 1039-1049. 10.1002/art.1780290816.CrossRefPubMed
18.
Kellgren JH, Lawrence JS: Atlas of standard radiographs. The epidemiology of chronic rheumatism; a symposium organized by the Council for International Organizations of Medical Science. Edited by: Kellgren JH. 1963, Oxford. Blackwell Scientific Publications, 2:
19.
Wluka AE, Wolfe R, Stuckey S, Cicuttini FM: How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis?. Ann Rheum Dis. 2004, 63 (3): 264-268. 10.1136/ard/2003.007666.CrossRefPubMedPubMedCentral
20.
Ding C, Garnero P, Cicuttini F, Scott F, Cooley H, Jones G: Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown. Osteoarthritis Cartilage. 2005, 13 (3): 198-205. 10.1016/j.joca.2004.11.007.CrossRefPubMed
21.
Felson DT, McLaughlin S, Goggins J, LaValley MP, Gale ME, Totterman S, Li W, Hill C, Gale D: Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med. 2003, 139 (5 Pt 1): 330-336.CrossRefPubMed
22.
Wluka AE, Stuckey S, Snaddon J, Cicuttini FM: The determinants of change in tibial cartilage volume in osteoarthritic knees. Arthritis Rheum. 2002, 46 (8): 2065-2072. 10.1002/art.10460.CrossRefPubMed
23.
Jones G, Ding C, Scott F, Glisson M, Cicuttini F: Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females. Osteoarthritis Cartilage. 2004, 12 (2): 169-174. 10.1016/j.joca.2003.08.010.CrossRefPubMed
24.
Cicuttini FM, Jones G, Forbes A, Wluka AE: Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study. Ann Rheum Dis. 2004, 63 (9): 1124-1127. 10.1136/ard.2004.021253.CrossRefPubMedPubMedCentral
25.
Ding C, Cicuttini F, Scott F, Boon C, Jones G: Association of prevalent and incident knee cartilage defects with loss of tibial and patellar cartilage: a longitudinal study. Arthritis Rheum. 2005, 52 (12): 3918-3927. 10.1002/art.21474.CrossRefPubMed
26.
Wluka AE, Ding C, Jones G, Cicuttini FM: The clinical correlates of articular cartilage defects in symptomatic knee osteoarthritis: a prospective study. Rheumatology (Oxford). 2005, 44 (10): 1311-1316. 10.1093/rheumatology/kei018.CrossRef
27.
Schipplein OD, Andriacchi TP: Interaction between active and passive knee stabilizers during level walking. J Orthop Res. 1991, 9 (1): 113-119. 10.1002/jor.1100090114.CrossRefPubMed
28.
Maly MR: Abnormal and cumulative loading in knee osteoarthritis. Curr Opin Rheumatol. 2008, 20 (5): 547-552. 10.1097/BOR.0b013e328307f58c.CrossRefPubMed
29.
Dougados M: Sodium hyaluronate therapy in osteoarthritis: arguments for a potential beneficial structural effect. Semin Arthritis Rheum. 2000, 30 (2 Suppl 1): 19-25.CrossRefPubMed
30.
Moreland LW: Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther. 2003, 5 (2): 54-67. 10.1186/ar623.CrossRefPubMedPubMedCentral
31.
Conrozier T, Chevalier X: Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis. Expert Opin Pharmacother. 2008, 9 (10): 1797-1804. 10.1517/14656566.9.10.1797.CrossRefPubMed
32.
Raynauld JP, Goldsmith CH, Bellamy N, Torrance GW, Polisson R, Belovich D, Pericak D, Tugwell P: Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis Cartilage. 2005, 13 (2): 111-119. 10.1016/j.joca.2004.10.018.CrossRefPubMed
Metadata
Title
Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial
Authors
Yuanyuan Wang
Stephen Hall
Fahad Hanna
Anita E Wluka
Gail Grant
Paul Marks
Marie Feletar
Flavia M Cicuttini
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2011
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-12-195

Other articles of this Issue 1/2011

BMC Musculoskeletal Disorders 1/2011 Go to the issue

Study protocol

Movement control exercise versus general exercise to reduce disability in patients with low back pain and movement control impairment. A randomised controlled trial

Study protocol

The effect of continuous ultrasound on chronic low back pain: protocol of a randomized controlled trial

Study protocol

Ankles back in randomized controlled trial (ABrCt): braces versus neuromuscular exercises for the secondary prevention of ankle sprains. Design of a randomised controlled trial

Study protocol

Minimally invasive computer-navigated total hip arthroplasty, following the concept of femur first and combined anteversion: design of a blinded randomized controlled trial

Research article

Reliability of maximal isometric knee strength testing with modified hand-held dynamometry in patients awaiting total knee arthroplasty: useful in research and individual patient settings? A reliability study

Research article

Symptomatic reactions, clinical outcomes and patient satisfaction associated with upper cervical chiropractic care: A prospective, multicenter, cohort study